Avalon GloboCare Corp., a Delaware-based company, has entered into a significant securities purchase agreement with Brown Stone Capital Ltd., an accredited investor. Under the agreement, Avalon will issue and sell 121,200 shares of its common stock and pre-funded warrants for an additional 354,300 shares to the investor, totaling $475,500. The transaction, which closed on July 17, 2025, generated net proceeds of $450,500 for Avalon after deducting offering expenses. Additionally, Avalon and the investor have entered into a registration rights agreement, committing to register the shares and warrants under the Securities Act of 1933. Avalon aims to file the registration statement by September 26, 2025, and seeks SEC approval within thirty to seventy-five days, depending on the review process.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.